Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Astellas Pharma

This page shows the latest Astellas Pharma news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Astellas’ Xospata for NHS use

NICE recommends Astellas’ Xospata for NHS use

However, following further discussions with Astellas, NICE has recommended Xospata monotherapy for treating adult patients with relapsed or refractory FLT3-positive AML. ... no longer works or they relapse,” said Jackie Williams, general manager for

Latest news

More from news
Approximately 1 fully matching, plus 132 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    AstraZeneca, Takeda, Astellas Pharma, Novo Nordisk and Recordati take up the final five positions, though only two - Takeda (3.9%) and Astellas (9.3%) - recorded growth. ... The data this article was based on is available in full online:

  • Case study: Action on Fistula Case study: Action on Fistula

    Client:Astellas Pharma EMEA Limited. Agency:Forster Communications. Campaign:Action on Fistula. Timescale:. Action on Fistula, launched in May 2014, is an innovative partnership between Astellas Pharma EMEA Limited and the ... Astellas’ investment in

  • Japanese pharma pulls no punches with post-Brexit UK Japanese pharma pulls no punches with post-Brexit UK

    Yasuo Sakae, vice president of corporate strategy and planning at Astellas Pharma Europe, told PME that the company’s regulatory team for the Europe, Middle East and Africa (EMEA) region is ... globally, as well as the presence of world-class

  • Deal Watch July 2016 Deal Watch July 2016

    $225m. $36m. LEO Pharma. AstraZeneca. $1, 115m. $115m. Astellas. Cytokinetics. $100m. ... In at numbers 2, 3 and 4 are the LEO-AstraZeneca deal with an upfront of $115m, Astellas-Cytokinetics at $95m and Almirall-Sun Pharma at $50m (see below).

  • Astellas: Ten years young Astellas: Ten years young

    s first decade of operations and hear from two of its senior executives on where Astellas is heading. ... In Europe sales rose 18.5% in 2014 and the region has been of increasing importance to Astellas.

More from intelligence
Approximately 1 fully matching, plus 20 partially matching documents found.

Latest appointments

  • Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands

    Taylor joins the agency from Astellas, where she was senior director of corporate communications, EMEA. ... run those very departments in global pharma companies and we therefore completely understand the challenges they face.

  • Astellas strengthens US and Canadian leadership team Astellas strengthens US and Canadian leadership team

    Astellas has promoted Steve Sabus (pictured right) to general manager of Astellas Pharma Canada, effective from 1 April this year. ... needs.”. Sabus joined Astellas in 2007 and has over 25 years’ experience in the pharmaceutical industry.

  • Astellas promotes Anthony Fiordaliso to VP, Americas finance Astellas promotes Anthony Fiordaliso to VP, Americas finance

    He first joined the pharma firm in 2010 from Schering-Plough. Astellas has promoted Anthony Fiodaliso to VP, Americas finance to oversee areas such as managerial reporting and budgeting, financial planning ... In his new role Fiordaliso will report

  • Dendreon appoints new R&D lead Dendreon appoints new R&D lead

    Joining from Astellas Pharma, Dr Brown most recently served as senior medical director of oncology, where he led US medical strategy for the prostate cancer drug Xtandi (enzalutamide).

  • Astellas appoints new senior VP Astellas appoints new senior VP

    Astellas.”. “I’m confident she will make an immediate and positive impact on both the team in the Americas, as well as the patients and partners we serve.”. ... She has also received multiple awards for leadership and innovation through her career

More from appointments
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Quick links

Infographics

Multimedia